Thread by @szusmani

1/7 Lots to unroll on #ASH20SU #ASH20 #mmsm abstracts, will do in several categories:

TOP TRANSLATIONAL
-ImmunoCell Study (ash.confex.com/ash/2020/webpr…)
-Discordance btwn IFE and MRD (ash.confex.com/ash/2020/webpr…)
@theMMRF @IMFmyeloma @Myeloma_Society @ASH_hematology

2/7 #ASH20SU #ASH20 #mmsm
-Immune ME Changes from MGUS/SMM to active MM (ash.confex.com/ash/2020/webpr…)
-PCL Genome/Transcriptome (ash.confex.com/ash/2020/webpr…)
-Resistance to BCMA Therapy (ash.confex.com/ash/2020/webpr…)
-Immunogenomic heterogeneity in MM (ash.confex.com/ash/2020/webpr…)

3/7
TOP CLINICAL NON-CART PHASE 1 RRMM #ASH20SU #ASH20 #mmsm
-Teclistamab (ash.confex.com/ash/2020/webpr…)
-MEDI2228 (ash.confex.com/ash/2020/webpr…)
-Talquetamab (ash.confex.com/ash/2020/webpr…)
-BFCR4350A (ash.confex.com/ash/2020/webpr…)
-TNB-383B (ash.confex.com/ash/2020/webpr…)

4/7
TOP CLINICAL CART PHASE 1 RRMM #ASH20SU #ASH20 #mmsm
-Cilta-cel (ash.confex.com/ash/2020/webpr…)
-Anti-BCMA & Anti-CD52 Allo-CART (ash.confex.com/ash/2020/webpr…)
-BB21217 (ash.confex.com/ash/2020/webpr…)
-CT053 (ash.confex.com/ash/2020/webpr…)
-P-BCMA-101 (ash.confex.com/ash/2020/webpr…)

5/7
TOP CLINICAL PHASE 2/3 RRMM #ASH20SU #ASH20 #mmsm
-Ixa-Kd IKEMA Update (ash.confex.com/ash/2020/webpr…)
-Dara-Pod APOLLO (ash.confex.com/ash/2020/webpr…)
-Dara-Kd CANDOR Survival Update (ash.confex.com/ash/2020/webpr…)

6/7
TOP 5 CLINICAL PHASE 2/3 Newly Diagnosed #ASH20SU #ASH20 #mmsm
-GRIFFIN Update (ash.confex.com/ash/2020/webpr…)
-EMN02/HO95 Update (ash.confex.com/ash/2020/webpr…)
-ANDROMEDA (ash.confex.com/ash/2020/webpr…)
-FORTE Survival Analysis (ash.confex.com/ash/2020/webpr…)

7/7
HONORABLE MENTIONS #ASH20SU #ASH20 #mmsm
-K-Cy-Dex vs Kd (ash.confex.com/ash/2020/webpr…)
-Dara-Cy-Dex +/- Pom (ash.confex.com/ash/2020/webpr…)
-1q21 Story in FORTE Trial (ash.confex.com/ash/2020/webpr…)
-Genomic/Transcriptomic Analysis on BELLINI Trial (ash.confex.com/ash/2020/webpr…)